Human Longevity, Inc. (HLI) is the genomics-based, technology-driven company creating the world's largest and most comprehensive database of whole genome, phenotype and clinical data. HLI is developing and applying large scale computing and machine learning to make novel discoveries to revolutionize the practice of medicine.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/05/16 | $220,000,000 | Series B |
Celgene Corporation GE Ventures Illumina, Inc | undisclosed |
